Vericel Corp. (VCEL)
42.36
-0.32
(-0.76%)
USD |
NASDAQ |
Aug 24, 16:00
42.36
0.00 (0.00%)
After-Hours: 19:56
Vericel Total Liabilities (Quarterly) : 132.82M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 132.82M |
| March 31, 2026 | 129.40M |
| December 31, 2025 | 133.33M |
| September 30, 2025 | 131.42M |
| June 30, 2025 | 128.80M |
| March 31, 2025 | 129.10M |
| December 31, 2024 | 140.76M |
| September 30, 2024 | 132.93M |
| June 30, 2024 | 133.86M |
| March 31, 2024 | 122.76M |
| December 31, 2023 | 127.70M |
| September 30, 2023 | 113.74M |
| June 30, 2023 | 111.78M |
| March 31, 2023 | 71.12M |
| December 31, 2022 | 80.73M |
| September 30, 2022 | 70.18M |
| June 30, 2022 | 70.00M |
| March 31, 2022 | 67.80M |
| December 31, 2021 | 73.24M |
| September 30, 2021 | 67.36M |
| June 30, 2021 | 70.85M |
| March 31, 2021 | 71.26M |
| December 31, 2020 | 71.35M |
| September 30, 2020 | 42.87M |
| June 30, 2020 | 39.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.81M |
| December 31, 2019 | 42.15M |
| September 30, 2019 | 40.54M |
| June 30, 2019 | 37.28M |
| March 31, 2019 | 38.17M |
| December 31, 2018 | 16.46M |
| September 30, 2018 | 29.99M |
| June 30, 2018 | 31.60M |
| March 31, 2018 | 31.47M |
| December 31, 2017 | 32.04M |
| September 30, 2017 | 23.54M |
| June 30, 2017 | 22.56M |
| March 31, 2017 | 25.08M |
| December 31, 2016 | 23.89M |
| September 30, 2016 | 16.63M |
| June 30, 2016 | 12.33M |
| March 31, 2016 | 13.83M |
| December 31, 2015 | 12.18M |
| September 30, 2015 | 9.408M |
| June 30, 2015 | 10.98M |
| March 31, 2015 | 12.79M |
| December 31, 2014 | 11.94M |
| September 30, 2014 | 12.60M |
| June 30, 2014 | 17.05M |
| March 31, 2014 | 6.109M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 141.52M |
| AbbVie, Inc. | 141.00B |
| Marker Therapeutics, Inc. | 2.42M |
| TG Therapeutics, Inc. | 1.036B |
| ADMA Biologics, Inc. | 276.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 502.87M |
| Shareholders Equity (Quarterly) | 370.04M |
| Debt to Equity Ratio | 0.2556 |
| Current Ratio | 5.039 |
| Net Debt Paydown Yield | 0.06% |